We provide 1 form of Anastrozole
Anastrozole
120511-73-1
|
293.164
|
1.475
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor. Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive locally advanced or metastatic breast cancer in postmenopausal women.
Anastrozole | anastrazole | anastrozol | arimidex
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor. Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive locally advanced or metastatic breast cancer in postmenopausal women.
Anastrozole | anastrazole | anastrozol | arimidex
$53/5 mg
(EBC)
1
We provide 2 compounds for Anastrozole
Anastrozole EP Impurity F
4-methylbenzene-1-sulfonic acid hydrate
p-Toluenesulfonic acid monohydrate
6192-52-5
190.03
-0.146
$19/5 mg
(EBC)
1
Anastrozole EP Impurity A
2-[3-(1-cyanoethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile
Alpha-Desmethyl anastrozole
1215780-15-6
279.148
1.076
$752/5 mg
(EBC)
1